Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Osteolife Biomedical I LLC
WARNING LETTER
•Osteolife Biomedical I LLC•February 4, 2022

Osteolife Biomedical I LLC – FDA Warning Letter, Feb 4, 2022

Record Details

The FDA issued a Warning Letter to OsteoLife Biomedical I LLC following an inspection from December 6, 2021, to February 4, 2022, which revealed significant deviations from 21 CFR Part 1271 for human cells, tissues, and cellular and tissue-based products (HCT/Ps).

Key violations include: 1. **Failure to prevent contamination (21 CFR 1271.220(a))**: Multiple batches of Freeze-Dried Particulate Bone from single donors were processed on the same day with the same equipment and technician without cleaning between batches. Post-processing cultures repeatedly tested positive for microorganisms (e.g., Bacillus, Stenotrophomonas maltophilia, Pseudomonas aeruginosa, Micrococcus luteus), yet other batches from the same donor were distributed. Additionally, a sterile sheet covered the laminar flow bench's return air slots during processing, increasing contamination risk. 2. **Failure to validate processes (21 CFR 1271.230(a))**: The manufacturing processes for Flexo-Plate, Flexo-Membrane, and Freeze-Dried Particulate Bone products were not adequately validated. Validation reports lacked in-process microbiological testing and acceptance criteria for contamination. 3. **Failure to monitor environmental conditions (21 CFR 1271.195(c))**: Environmental monitoring for microorganisms was conducted approximately quarterly and not

Company
Osteolife Biomedical I LLC
Inspection date
February 4, 2022
Product type
Biologics
Office
Office of Biological Products Operations - Division I
Person
  • Michael W. Roosevelt (Program Division Director)
View Company Profile

ID · 24458929-f02e-481c-af69-9cb14309ebbb

Violation Codes5
21 CFR 127121 CFR 1271.220(a)21 CFR 1271.230(a)21 CFR 1271.195(c)21 CFR 1271.160(b)(6)

Full citation text and observation details available on the Dashboard.

Other documents for Osteolife Biomedical I LLC
  • 483 - 2023-02-14February 14, 2023
  • 483 - 2022-02-04February 4, 2022

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Osteolife Biomedical I LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.